Among them, Fli-1 signaling is associated with the occurrence of GBM and is highly expressed in radiotherapy- and temozolomide-resistant glioblastomas, and can regulate HSPB1 at the transcriptional level. The gene discussed is FLI1; the disease is glioblastoma.